BSX (STOCKS)
Boston Scientific Corp.
$46.645800
-0.264200 (-0.56%)
Prev close: $46.910000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Michael F. Mahoney
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $69,494.76M
- Employees
- 53,000
- P/E (TTM)
- 19.67
- P/B (TTM)
- 2.70
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $20.62B |
| Benefits Costs and Expenses | $16.87B |
| Cost Of Revenue | $6.36B |
| Costs And Expenses | $16.87B |
| Gross Profit | $14.26B |
| Operating Expenses | $10.47B |
| Selling, General, and Administrative Expenses | $7.07B |
| Other Operating Expenses | $3.39B |
| Operating Income/Loss | $3.79B |
| Income/Loss From Continuing Operations After Tax | $3.56B |
| Income/Loss From Continuing Operations Before Tax | $3.74B |
| Income Tax Expense/Benefit | $183.00M |
| Interest Expense, Operating | $357.00M |
| Net Income/Loss | $3.56B |
| Net Income/Loss Attributable To Noncontrolling Interest | -$6.00M |
| Net Income/Loss Attributable To Parent | $3.57B |
| Net Income/Loss Available To Common Stockholders, Basic | $3.57B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $2.41 |
| Diluted Earnings Per Share | $2.39 |
| Basic Average Shares | 4,447,300,000 |
| Diluted Average Shares | 4,484,500,000 |
| Assets | $44.35B |
| Current Assets | $8.68B |
| Inventory | $3.12B |
| Other Current Assets | $5.57B |
| Noncurrent Assets | $35.67B |
| Fixed Assets | $4.06B |
| Intangible Assets | $7.06B |
| Other Non-current Assets | $24.54B |
| Liabilities | $18.25B |
| Current Liabilities | $4.57B |
| Accounts Payable | $1.14B |
| Other Current Liabilities | $3.43B |
| Noncurrent Liabilities | $13.68B |
| Equity | $26.10B |
| Equity Attributable To Noncontrolling Interest | $240.00M |
| Equity Attributable To Parent | $25.86B |
| Liabilities And Equity | $44.35B |
| Net Cash Flow From Operating Activities | $4.34B |
| Net Cash Flow From Operating Activities, Continuing | $4.34B |
| Net Cash Flow From Investing Activities | -$2.73B |
| Net Cash Flow From Investing Activities, Continuing | -$2.73B |
| Net Cash Flow From Financing Activities | -$888.00M |
| Net Cash Flow From Financing Activities, Continuing | -$888.00M |
| Exchange Gains/Losses | $3.00M |
| Net Cash Flow | $725.00M |
| Net Cash Flow, Continuing | $722.00M |
| Comprehensive Income/Loss | $3.20B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $6.00M |
| Comprehensive Income/Loss Attributable To Parent | $3.19B |
| Other Comprehensive Income/Loss | -$358.00M |